Novum draws scrutiny for raising drug prices thousands of dollars

By Lisa Schencker

Chicago Tribune

CHICAGO — A pharmaceutical company that’s selling skin medications for thousands of dollars is the latest to take heat in the nationwide furor over drug pricing.

Novum Pharma as of Sept. 12 was charging pharmacies a wholesale price of $7,968 for 48-gram tubes of skin gel Alcortin A, which can be used to treat eczema and certain skin infections, and the same price for 60-gram tubes of Aloquin, also used on eczema and skin infections. That price was up 128 percent since June, according to the Elsevier Clinical Solutions’ Gold Standard Drug Database. Chicago-based Novum was selling 29-gram tubes of Novacort, also used to treat eczema and skin infections, for $5,952 wholesale as of Sept. 12 — a nearly 71 percent increase from June.

Consumers typically are charged more than a manufacturer’s wholesale price, before insurance or cost-saving programs kick in.

The Chicago Tribune confirmed that Alcortin A is selling at some Chicago-area pharmacies for $8,000 or more, before insurance. The company’s two other medications, Aloquin and Novacort, also are selling for thousands of dollars each at local pharmacies.

Novum bought the three drugs from Primus Pharmaceuticals during the first half of 2015. As recently as Jan. 1, 2015, Alcortin A had a wholesale price of $189, Aloquin had a wholesale price of $201, and Novacort had a wholesale price of $121, according to Elsevier.

Novum said in an emailed statement Thursday that many of the prices, first quoted by the Financial Times, are inaccurate and are not the prices Novum charges. But Novum did not offer any alternate numbers.

Novum, which was founded last year, describes itself as a small “specialty pharmaceutical company focused on acquiring and licensing under promoted/mature products.”

“The prices cited in the (Financial Times) article include thousands of dollars in extra charges that are added by various third-party middlemen and passed onto patients,” Novum said in the statement. “This practice reflects one of the many fundamental challenges inherent in the health care system today that add to the cost of access for patients.” Rand Walton, a Novum spokesman, declined to elaborate on the “extra charges.”

Novum also said that through its patient access programs, most patients with private insurance pay no co-pay for Novum products. Those paying for the products without insurance never have to pay more than $35, Novum said.

The company said it reinvests “virtually all of its pricing directly and immediately into its patient support program, which severely limits cost to insurers and to the health care system in general.”

Garth Reynolds, executive director of the Illinois Pharmacists Association, said there are alternate, significantly less expensive drugs available to treat the same skin conditions. Reynolds said pharmaceutical companies have a right to set prices wherever they want but they have to be careful not to price themselves out of the market.

He said the price of Alcortin A is mind-boggling.

“I would never have thought in all my years that we would have a topical medication that would be that expensive,” Reynolds said.

Over the past year, a number of pharmaceutical companies and executives have come under fire for what many see as unreasonably high drug prices.

“Companies are raising the prices because they can,” said Peter Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center in New York. “It’s much easier to raise your revenue by raising your price than by increasing the number of people taking your drug or proving it works better than the alternative.”

A congressional committee grilled Mylan CEO Heather Bresch last week over the price of EpiPens.

EpiPens contain epinephrine, that when injected into a person’s thigh, can counter often life-threatening allergic reactions. Mylan has raised the price of EpiPens more than 500 percent since early 2008, charging pharmacies a wholesale price of more than $600 for a two-pack of the devices as of May, according to the Elsevier drug database.

In recent weeks, Mylan has tried to quell the outrage by offering $300 savings cards to patients with private insurance and expanding its patient assistance program for underinsured and uninsured patients. It also said it will offer a generic version of EpiPen priced at $300. Bresch told the committee last week that Mylan has invested heavily in making the EpiPen better and more widely available.

She also said Mylan makes only about a $100 profit on each EpiPen two-pack, though The Wall Street Journal reported Monday that Mylan actually makes a profit of $160 before taxes. Mylan spokeswoman Nina Devlin said in a statement Monday the Journal story is “misleading” and the way Mylan reached the $100 estimate is “standard.”

Savings cards and co-pay assistance programs also draw criticism from many who say they do little to reduce costs for the overall health care system.

“Ultimately this always trickles down to the consumer,” said Michael Rea, founder and CEO of Rx Savings Solutions. Rea’s company sells software to insurers and employers aimed at helping consumers understand their health care options. “Maybe the insurance company has to pay the majority of that big price tag, but that shows up in premiums next year.”

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Business

A closing sign hangs above the entrance of the Big Lots at Evergreen and Madison on Monday, July 22, 2024, in Everett, Washington. (Ryan Berry / The Herald)
Big Lots announces it will shutter Everett and Lynnwood stores

The Marysville store will remain open for now. The retailer reported declining sales in the first quarter of the year.

George Montemor poses for a photo in front of his office in Lynnwood, Washington on Tuesday, July 30, 2024.  (Annie Barker / The Herald)
Despite high mortgage rates, Snohomish County home market still competitive

Snohomish County homes priced from $550K to $850K are pulling in multiple offers and selling quickly.

Henry M. Jackson High School’s robotic team, Jack in the Bot, shake hands at the 2024 Indiana Robotics Invitational.(Henry M. Jackson High School)
Mill Creek robotics team — Jack in the Bot — wins big

Henry M. Jackson High School students took first place at the Indiana Robotic Invitational for the second year in a row.

The computer science and robotics and artificial intelligence department faculty includes (left to right) faculty department head Allison Obourn; Dean Carey Schroyer; Ishaani Priyadarshini; ROBAI department head Sirine Maalej and Charlene Lugli. PHOTO: Arutyun Sargsyan / Edmonds College.
Edmonds College to offer 2 new four-year degree programs

The college is accepting applications for bachelor programs in computer science as well as robotics and artificial intelligence.

FILE — Boeing 737 MAX8 airplanes on the assembly line at the Boeing plant in Renton, Wash., on March 27, 2019. Boeing said on Wednesday, Feb. 21, 2024, that it was shaking up the leadership in its commercial airplanes unit after a harrowing incident last month during which a piece fell off a 737 Max 9 jet in flight. (Ruth Fremson/The New York Times)
Federal judge rejects Boeing’s guilty plea related to 737 Max crashes

The plea agreement included a fine of up to $487 million and three years of probation.

Neetha Hsu practices a command with Marley, left, and Andie Holsten practices with Oshie, right, during a puppy training class at The Everett Zoom Room in Everett, Washington on Wednesday, July 3, 2024. (Annie Barker / The Herald)
Tricks of the trade: New Everett dog training gym is a people-pleaser

Everett Zoom Room offers training for puppies, dogs and their owners: “We don’t train dogs, we train the people who love them.”

Andy Bronson/ The Herald 

Everett mayor Ray Stephenson looks over the city on Tuesday, Jan. 5, 2015 in Everett, Wa. Stephanson sees  Utah’s “housing first” model – dealing with homelessness first before tackling related issues – is one Everett and Snohomish County should adopt.

Local:issuesStephanson

Shot on: 1/5/16
Economic Alliance taps former Everett mayor as CEO

Ray Stephanson will serve as the interim leader of the Snohomish County group.

Molbak's Garden + Home in Woodinville, Washington will close on Jan. 28. (Photo courtesy of Molbak's)
After tumultuous year, Molbak’s is being demolished in Woodinville

The beloved garden store closed in January. And a fundraising initiative to revitalize the space fell short.

Everett Mayor Cassie Franklin, Advanced Manufacturing Skills Center executive director Larry Cluphf, Boeing Director of manufacturing and safety Cameron Myers, Edmonds College President Amit Singh, U.S. Rep. Rick Larsen, and Snohomish County Executive Dave Somers participate in a ribbon-cutting ceremony on Tuesday, July 2 celebrating the opening of a new fuselage training lab at Paine Field. Credit: Arutyun Sargsyan / Edmonds College
‘Magic happens’: Paine Field aerospace center dedicates new hands-on lab

Last month, Edmonds College officials cut the ribbon on a new training lab — a section of a 12-ton Boeing 767 tanker.

Gov. Jay Inslee presents CEO Fredrik Hellstrom with the Swedish flag during a grand opening ceremony for Sweden-based Echandia on Tuesday, July 30, 2024, in Marysville, Washington. (Ryan Berry / The Herald)
Swedish battery maker opens first U.S. facility in Marysville

Echandia’s marine battery systems power everything from tug boats to passenger and car ferries.

Helion Energy CEO and co-founder David Kirtley talks to Governor Jay Inslee about Trenta, Helion’s 6th fusion prototype, during a tour of their facility on Tuesday, July 9, 2024 in Everett, Washington. (Olivia Vanni / The Herald)
State grants Everett-based Helion a fusion energy license

The permit allows Helion to use radioactive materials to operate the company’s fusion generator.

People walk past the new J.sweets storefront in Alderwood Mall on Thursday, July 25, 2024, in Lynnwood, Washington. (Olivia Vanni / The Herald)
New Japanese-style sweets shop to open in Lynnwood

J. Sweets, offering traditional Japanese and western style treats opens, could open by early August at the Alderwood mall.

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.